Abstract

Aims:Cochlear implant (CI) is a widely accepted device to patients with severe to profound sensorineural hearing loss to replace the normal hearing pathway. Since a portion of the device is implanted under the skin, possible immune alteration may occur. Our aim was to assess the production of some selected pro-inflammatory and anti-inflammatory cytokines in patients with cochlear implants and their impact on hearing outcomes. Material and Methods: Our study was conducted on 25 cochlear implanted patients who were subjected to IL-1β, IL2, IFN-γ and IL6 laboratory assessment preoperatively, postoperatively, 6 months after CI and 2 years after CI. Simultaneously, impedance and neural response telemetry (NRT) were measured and the data were analyzed statistically in relation to the laboratory findings. Results:No statistically significant difference was found between the levels of cytokines at different times of assessment except a significant increase of IL-1β at first fitting postoperatively in comparison to preoperative sample. Also, no statistically significant difference was found as regards values of impedance and NRT except a significant decrease of postoperative measures of NRT in comparison to intraoperative measures without any malfunction. Conclusion:There is a minimal immune alteration immediately after CI without any functional affection which may be attributed to the trauma of the implantation surgery rather than foreign body immune response.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.